United States President Donald Trump announced that he would sign an executive order on Monday that will "almost immediately" reduce prescription drug and pharmaceutical prices by 30-80%.
"They will rise throughout the World in order to equalize and, for the first time in many years, bring...
United States President Donald Trump said that he has decided on the tariff rates for imports of pharmaceuticals and that he will announce them sometime "over the next two weeks."
He offered no further details in his brief reply to a reporter's question in the Oval Office. Drugmakers have...
Biopharmaceutical company Regulus Therapeutics Inc. announced on Wednesday it entered into an agreement to be acquired by Novartis AG in a deal worth up to $17. billionNovartis will make an initial payment of $7.00 per share, or a total of $0.8 billion, while Regulus shareholders will also receive "a...
GSK plc announced on Wednesday its turnover in the first quarter of 2023 amounted to £6.95 billion, rising 2% from the same period in 2024. The increase at a constant exchange rate was 4%.Total earnings per share (EPS) soared 55% year on year to 39.7 pence, while core EPS rose 4% to 44.9...
Merck & Co. Inc. announced on Tuesday that the company is set to invest $1 billion in a new facility in Delaware.The production will include new drugs and a new version of Keytruda, its cancer treatment that will soon have its first manufacturing site within the United States. The new version of the...
United States President Donald Trump signed an executive order targeting high drug prices in the US. The move directed the Food and Drug Administration (FDA) to speed up approvals for generic and biosimilar drugs and expand state programs to import cheaper medicines from...
The United States Commerce Department launched investigations into imports of pharmaceuticals and semiconductor products. The inquiries, announced through a notice on the Federal Register, aim to assess whether these imports pose a risk to national security.
The investigation was...
United States President Donald Trump said at the National Republican Congressional Committee (NRCC) dinner that the US is "very shortly" going to announce a "major tariff" on pharmaceuticals."We're going to tariff our pharmaceuticals and once we do that, they're going to come rushing back into...
F. Hoffmann-La Roche AG said on Thursday its annual sales in 2024 reached 60.5 billion Swiss francs, climbing 3% in Swiss francs and 7% at constant exchange rates (CER) from the same period a year earlier. Sales in the pharmaceuticals division grew 8% at CER to 46.2 billion Swiss francs, while...
Roche Group said on Wednesday that its sales stood at 15.1 billion Swiss francs in the third quarter of 2024, climbing 6% in Swiss francs and 9% at constant exchange rates from the same period a year earlier. Sales in the pharmaceuticals division grew 10% at constant exchange rates to 11.6...
This website uses cookies to ensure you get the best experience. Our Terms of Use and Data Protection Policy explain the data we collect, why we collect them, and how we may share them.
